New clues raise hopes for better treatment of RSV in babies
Future therapies for respiratory syncytial virus (RSV) must target both the virus and the immune response to ensure babies get the best possible outcomes, a new study by researchers at UCL and Great…
Read the full articleYou might also wanna read
Animal-free lung model unlocks better treatments for RSV in babies
Future therapies for respiratory syncytial virus (RSV) must target both the virus and its immune response to ensure babies get the best poss
New Lung Model Reveals RSV Immune Response, Points to Better Treatments
Researchers used pediatric airway cells, blood vessel cells, and neutrophils to build an in vitro model of infant lungs that allowed them to
RSV Preventive Strategies Tied to Fewer Bronchiolitis Cases
Administration of nirsevimab and RSV vaccination in pregnant women are tied to significant reductions in hospitalized days and oxygen requir
Clinical trials seek way to prevent RSV, a common infection in infants and toddlers
Interview with pediatric infectious disease specialist Joe Domachowske, MD
Majority of Moms, Newborns Get RSV Protection
Most pregnant women receive the maternal vaccine against respiratory syncytial virus, and most newborns leave the hospital protected, but ga
Medication shows promise in preventing RSV, a sometimes deadly infection, in babies
Interview with pediatric infectious disease specialist Joe Domachowske, MD
Comments
Sign in to join the conversation.
No comments yet. Be the first.